Director of Research
In the Ley Group, we specialise in developing new synthesis methods and applying them to the construction of biologically important molecules. Over the years we have completed the total synthesis of many natural products, including: spongistatin 1 (anti-mitotic agent); rapamycin (immunosuppressant); thapsigargin (SERCA pumps inhibitor); azadirachtin (insect antifeedant); and bengazole A (fungicide). In addition to our research on natural product synthesis, we also pioneered flow chemistry and machine assisted synthesis.
For more detailed research information and our publication list, please see our legacy group website.
Completed Natural Products

Publications
Oxidation reactions in segmented and continuous flow chemical processing using an N -(tert -Butyl)phenylsulfinimidoyl chloride monolith
Synlett
(2011)
869
(doi: 10.1055/s-0030-1259923)
Total synthesis of chloptosin: A dimeric cyclohexapeptide
Chemistry A European Journal
(2011)
17
4183
(doi: 10.1002/chem.201003216)
Continuous Flow Processing of Slurries: Evaluation of an Agitated Cell Reactor
Organic Process Research & Development
(2011)
15
693
(doi: 10.1021/op2000223)
Diastereoselective ChaināElongation Reactions Using Microreactors for Applications in Complex Molecule Assembly
Chemistry A European Journal
(2011)
17
3398
(doi: 10.1002/chem.201003148)
Allosteric modulation of hormone release from thyroxine and corticosteroid-binding globulins
Journal of Biological Chemistry
(2011)
286
16163
(doi: 10.1074/jbc.m110.171082)
The Continuous-Flow Synthesis of Carboxylic Acids using CO2 in a Tube-In-Tube Gas Permeable Membrane Reactor
Angew Chem Int Ed Engl
(2011)
50
1190
(doi: 10.1002/anie.201006618)
A fully automated, multistep flow synthesis of 5-amino-4-cyano-1,2,3-triazoles.
Org Biomol Chem
(2011)
9
1938
(doi: 10.1039/c0ob00815j)
Flow synthesis of organic azides and the multistep synthesis of imines and amines using a new monolithic triphenylphosphine reagent
Org Biomol Chem
(2011)
9
1927
(doi: 10.1039/c0ob00813c)
New Synthetic Technologies in Medicinal Chemistry Foreword
(2011)
11
V
(doi: 10.1039/9781849733052-FP005)
- ‹ previous
- Page 26